Method of delivering cell therapy to a target site
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-035/12
A61K-035/00
A61K-049/04
A61K-049/06
A61K-035/28
A61K-035/32
출원번호
US-0400059
(2009-03-09)
등록번호
US-8784800
(2014-07-22)
발명자
/ 주소
Morris, Mary M.
Gardeski, Kenneth
Verard, Laurent
Wu, Kevin Thomas
Neidert, Michael R.
출원인 / 주소
Medtronic, Inc.
대리인 / 주소
Barry, Carol F.
인용정보
피인용 횟수 :
0인용 특허 :
9
초록▼
A method of delivering therapy to a target site. The method includes (a) obtaining a base image of the target site, (b) injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site via a needle passing through a catheter, (c) collecting seq
A method of delivering therapy to a target site. The method includes (a) obtaining a base image of the target site, (b) injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site via a needle passing through a catheter, (c) collecting sequential fluoroscopic images of a contrast agent dispersion cloud at the first injection location, (d) determining a contrast agent dispersion area from the sequential fluoroscopic images, (e) determining a therapeutic agent dispersion area from the contrast agent dispersion area, (f) marking the therapeutic agent dispersion area on the base image of the target site, and (g) repeating (b) through (f) until the target site is substantially covered with overlapping therapeutic agent dispersion areas corresponding to a plurality of injections at a plurality of injection locations at the target site.
대표청구항▼
1. A method of delivering therapy to a target site, the method comprising: (a) obtaining a base image of the target site;(b) navigating a catheter to the target site;(c) injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site;(d) colle
1. A method of delivering therapy to a target site, the method comprising: (a) obtaining a base image of the target site;(b) navigating a catheter to the target site;(c) injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site;(d) collecting sequential fluoroscopic images of a contrast agent dispersion cloud at the first injection location;(e) determining a contrast agent dispersion region from the sequential fluoroscopic images;(f) identifying a tissue type of the first injection location;(g) determining a therapeutic agent dispersion region from the contrast agent dispersion region;(h) marking the therapeutic agent dispersion region on the base image of the target site; and(i) repeating (b) through (h) until the target site is substantially covered with overlapping therapeutic agent dispersion regions corresponding to a plurality of injections at a plurality of injection locations at the target site,wherein a plurality of the therapeutic agent dispersion regions are presented on the base image at the same time. 2. The method of claim 1, wherein determining a contrast agent dispersion region includes determining a size of the contrast agent dispersion cloud as a function of time. 3. The method of claim 2, wherein determining a contrast agent dispersion region includes determining a duration of the contrast agent dispersion cloud as a function of time. 4. The method of claim 3, wherein determining a contrast agent dispersion region includes determining an intensity of the contrast agent dispersion cloud as a function of time. 5. The method of claim 4, wherein determining a contrast agent dispersion region includes determining a time derivative of intensity of the contrast agent dispersion cloud as a function of time. 6. The method of claim 1, wherein determining a therapeutic agent dispersion region from the contrast agent dispersion region comprises determining a therapeutic agent dispersion area from the contrast agent dispersion area using two-dimensional fluoroscopic images. 7. The method of claim 6, wherein determining a therapeutic agent dispersion area from the contrast agent dispersion area comprises correlating the therapeutic agent dispersion area and the contrast agent dispersion with a parameter that depends on a tissue type of the injection location. 8. The method of claim 1, wherein injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site comprises injecting a dose through an injection needle, the injection needle passing through a deflectable catheter, the deflectable catheter including a removable navigation insert. 9. The method of claim 1, wherein injecting a dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site comprises injecting a dose through an injection needle, the injection needle passing through an integrated deflectable multi-lumen navigation/therapy delivery catheter. 10. The method of claim 1, wherein the therapeutic agent comprises at least one of the following types of cells: islet cells, pluripotent stern cells, mesenchymal stem cells, endodermal stem cells, ectodermal stem cells, hepatocytes, chondrocytes, osteoblasts, neuronal cells, glial cells, smooth muscle cells, endothelial cells, skeletal myoblasts, myoblasts, macrophages, erythrocytes, platelets, and fibroblasts. 11. The method of claim 1, wherein determining the therapeutic agent dispersion region comprises determining the therapeutic dispersion region based on the tissue type identified at the first injection location in combination with the contrast agent dispersion region. 12. The method of claim 1, wherein identifying a tissue type of the first injection location comprises analysis of the sequential fluoroscopic images of the contrast agent dispersion cloud at the first injection location. 13. A method of delivering therapy to a target site, the method comprising: obtaining a base image of the target site;navigating a catheter including a delivery needle to the target site;injecting through the needle a first dose of a mix of a therapeutic agent and a contrast agent into a first injection location at the target site;collecting sequential fluoroscopic images of a contrast agent dispersion cloud at the first injection location;determining a contrast agent dispersion region from the sequential fluoroscopic images of the first injection location;identifying a tissue type of the first injection location;determining a therapeutic agent dispersion region from the contrast agent dispersion region of the first injection location;marking the therapeutic agent dispersion region of the first injection location on the base image of the target site;injecting through the needle a second dose of a mix of a therapeutic agent and a contrast agent into a second injection location different from the first injection location at the target site; anddetermining a therapeutic agent dispersion region for the second injection location and marking the therapeutic agent dispersion region for the second injection location on the base image of the target site, wherein a plurality of the therapeutic agent dispersion regions are presented on the base image at the same time. 14. The method of claim 13, further comprising collecting sequential fluoroscopic images of a contrast agent dispersion cloud at the second injection location. 15. The method of claim 14, further comprising determining a contrast agent dispersion region from the sequential fluoroscopic images at the second injection location. 16. The method of claim 15, further comprising determining a therapeutic agent dispersion region from the contrast agent dispersion region at the second injection location. 17. The method of claim 16, further comprising marking the therapeutic agent dispersion region of the second injection location on the base image of the target site. 18. The method of claim 13, wherein determining the therapeutic agent dispersion region comprises determining the therapeutic dispersion region based on the tissue type identified at the first injection location in combination with the contrast agent dispersion region of the first injection location. 19. The method of claim 13, wherein identifying a tissue type of the first injection location comprises analysis of the sequential fluoroscopic images of the contrast agent dispersion cloud at the first injection location.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (9)
Wittkampf Frederik H. M.,NLX, Catheter location system and method.
Glines, Robert C.; Weller, Gary B., Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body.
Gillies George T. ; Kucharczyk John ; Broaddus William C. ; Latchaw Richard, MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging.
Jascob, Bradley; Simon, David; Kessman, Paul; Smith, Aaron, Method and apparatus for electromagnetic navigation of a surgical probe near a metal object.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.